GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rivalGlaxoSmithKline’s drug for anaemia caused by chronic kidney disease daprodustat has been approved in Japan, taking on a recently approved rival from Astellas. Marketed Share XGSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rivalhttps://pharmaphorum.com/news/gsk-kidney-disease-anaemia-drug-approved-in-japan-taking-on-astellas-rival/